Testing effectiveness (Phase 2)WithdrawnNCT06006286
What this trial is testing
A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma
Who this might be right for
Metastatic Hepatocellular Carcinoma
M.D. Anderson Cancer Center